관상동맥 커팅 풍선 시장 : 시장 기회, 성장 촉진요인, 산업 동향 분석, 예측(2025-2034년)

The Global Coronary Cutting Balloon Market was valued at USD 141.1 million in 2024 and is estimated to grow at a CAGR of 9.8% to reach USD 395.6 million by 2034. This acceleration is largely driven by the increasing global burden of cardiovascular conditions, along with growing advancements in medical technology and rising adoption of minimally invasive cardiac procedures. Factors such as poor nutrition, physical inactivity, hypertension, and the rising diabetic population contribute heavily to the development of atherosclerotic plaque in coronary arteries.

As more patients present with complex lesions, particularly those resistant to traditional treatment, coronary cutting balloons are being increasingly utilized for their accuracy and safety in plaque modification. The growing use of advanced diagnostic tools like intravascular imaging and coronary angiography has allowed for earlier detection of complex arterial blockages, enhancing timely treatment using cutting balloons. These specialized devices combine a conventional balloon catheter with microblades that create precise incisions during inflation, facilitating safer and more effective lesion dilation. With coronary artery disease (CAD) rising across both emerging and developed healthcare markets, clinical reliance on these tools continues to gain traction worldwide.

The calcified lesion treatment segment is projected to generate USD 229.3 million in 2034. The increasing prevalence of heavily calcified coronary artery disease, especially among elderly populations and diabetic individuals, has made this treatment area a key focus. Cutting balloons provide interventional cardiologists with greater control by enabling refined plaque scoring, which enhances stent delivery and expansion during procedures. With procedural volumes rising for complex percutaneous coronary interventions (PCIs), the clinical need for reliable lesion preparation devices like cutting balloons continues to increase. Their role in improving procedural success rates and outcomes has accelerated their adoption across cardiovascular care settings globally.

In 2024, the hospitals segment, captured the largest share and projected to continue expanding during 2025-2024. Hospitals are equipped with advanced catheterization labs and multidisciplinary cardiac teams, making them the primary centers for performing complex PCIs. The ability to handle high-risk CAD cases, including severe blockages and in-stent restenosis, gives hospitals a leading edge in utilizing coronary cutting balloons effectively. Growing healthcare investments and infrastructure development in tertiary and urban hospitals, along with 24/7 availability of cardiac services, further support the strong demand from this segment.

United States Coronary Cutting Balloon Market generated USD 64.4 million in 2024. The U.S. remains at the forefront of cutting balloon adoption due to its large CAD patient pool, widespread availability of advanced cardiac facilities, and high volume of PCI procedures. Early adoption of innovative medical devices and favorable reimbursement policies continue to support the market's growth. In addition, the rising use of technologies for imaging inside blood vessels further supports the clinical use of cutting balloons in identifying and treating complex lesions. Ongoing innovation from key players ensures consistent supply and performance enhancements that contribute to market expansion.

Leading companies in this market include LEPU MEDICAL, SHENQI MEDICAL, and Boston Scientific. To strengthen their market position, companies in the coronary cutting balloon space are deploying several targeted strategies. They are investing heavily in R&D to innovate next-generation devices that offer greater precision and safety. Geographic expansion through regional partnerships and regulatory approvals in high-growth countries is helping firms enter untapped markets. Companies are also focusing on physician training programs to boost awareness and encourage broader adoption of cutting balloons in complex procedures. Strengthening supply chains, optimizing pricing models, and expanding indications for use are other approaches being adopted to maintain competitive advantage and increase global footprint.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates & calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Number of blades
  • 2.2.3 Application
  • 2.2.4 End Use
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Value addition at each stage
  • 3.1.3 Factor affecting the value chain
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of cardiovascular diseases
    • 3.2.1.2 Growing technological advancements
    • 3.2.1.3 Demand for precise and safer plaque-modification tools
    • 3.2.1.4 Rising awareness and improved diagnostic methods
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High product cost coupled with competition from alternative technologies
  • 3.2.3 Opportunities
    • 3.2.3.1 Growing adoption of minimally invasive cardiovascular procedures
    • 3.2.3.2 Demand in emerging and untapped markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
    • 3.5.2.1 High-pressure coronary cutting balloon
• 3.6 Price trends, by product
• 3.7 Future market trends
• 3.8 Reimbursement scenario
• 3.9 Gap analysis
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 Global
  • 4.2.2 North America
  • 4.2.3 Europe
  • 4.2.4 Asia Pacific
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Number of Blades, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Three blades
• 5.3 Four blades

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Calcified lesion treatment
• 6.3 In-stent restenosis
• 6.4 Lesion preparation

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Catheterization laboratories
• 7.4 Ambulatory surgery centers
• 7.5 Other end use

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Rest of the world (RoW)

Chapter 9 Company Profiles

• 9.1 Boston Scientific
• 9.2 LEPU MEDICAL
• 9.3 SHENQI MEDICAL